OpenVSafe by OpenVAERS
Search V-safe

DPD-97128-13421

3 vaccinations 4 coded responses 14 check-ins 4 free-text entries 0 call cases
Sex
Female
Age at first dose
31-35
ZIP prefix
945 / CA
Registered
2021-04-01
Relationship
Self
Race
White
Ethnicity
Not Hispanic or Latino

Timeline

  1. 2021-04-01
    Registered in v-safe
  2. 2021-04-01
    Dose 1 — Pfizer-BioNTech
  3. 2021-04-01
    Health check-in — day 0, dose 1
    Feeling: Good · None
    Adult check-in
  4. 2021-04-17
    Health check-in — day 14, dose 1
    Feeling: Good
    Adult check-in
  5. 2021-04-22
    Dose 2 — Pfizer-BioNTech
  6. 2021-04-23
    Survey response — days 1–6 daily, dose 2
    MedDRA: Pyrexia — Feeling: Poor · Site: Pain, Swelling · Fever · Chills, Headache, Muscle or body aches, Fatigue or tiredness, Nausea · Be unable to do your normal daily activities
    Free text: Fever 101.3
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  7. 2021-04-24
    Health check-in — days 1–6 daily, dose 2
    Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tiredness
    Adult check-in
  8. 2021-04-25
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness — Feeling: Fair · Site: Pain · Fatigue or tiredness
    Free text: Dizziness & increase in menstration flow
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  9. 2021-04-26
    Survey response — days 1–6 daily, dose 2
    MedDRA: Dizziness — Feeling: Fair · Site: Pain · Fatigue or tiredness
    Free text: Little dizziness intermittently
    MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
  10. 2021-04-27
    Health check-in — days 1–6 daily, dose 2
    Feeling: Fair · Headache, Fatigue or tiredness
    Adult check-in
  11. 2021-05-01
    Health check-in — day 7, dose 2
    Feeling: Good · Fatigue or tiredness
    Adult check-in
  12. 2021-10-21
    Health check-in — 6 months, dose 2
    Feeling: Good
    Adult check-in
  13. 2021-10-22
    Dose 3 — Pfizer-BioNTech
  14. 2021-10-22
    Health check-in — day 0, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  15. 2021-10-23
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain, Swelling · Headache, Fatigue or tiredness
    Adult check-in
  16. 2021-10-24
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · Headache, Fatigue or tiredness
    Adult check-in
  17. 2021-10-26
    Health check-in — days 1–6 daily, dose 3
    Feeling: Good · Site: Pain · None
    Adult check-in
  18. 2022-10-24
    Survey response — 12 months, dose 3
    MedDRA: Chills, Lymph node pain, Pain in extremity, Pyrexia — Feeling: Good · Be unable to do your normal daily activities
    Free text: Fever and chills, sore arm and sore gland/underarm area
    MedDRA releases: 2024-11 · check-in free text available

Vaccinations

DoseDateManufacturerCo-administered
12021-04-01Pfizer-BioNTech
22021-04-22Pfizer-BioNTech
32021-10-22Pfizer-BioNTech No

Free text

Release 7 — days 1–6 daily, dose 2

2021-04-23

Systemic reaction (other): Fever 101.3

2021-04-25

Systemic reaction (other): Dizziness & increase in menstration flow

Release 8 — days 1–6 daily, dose 2

2021-04-26

Systemic reaction (other): Little dizziness intermittently

Release 12 — 12 months, dose 3

2022-10-24

Symptoms: Fever and chills, sore arm and sore gland/underarm area

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

FieldPreferred term2021-092023-042024-11
SDChills · · ✓
SDLymph node pain · · ✓
SDPain in extremity · · ✓
SDPyrexia · · ✓
SRODizziness ✓ ✓ ✓
SROPyrexia ✓ ✓ ✓

✓ active code · ○ coded but marked inactive · blank = not in that release

Loading…